IKT
#3222
Inhibikase Therapeutics, Inc. - Common Stock
2.4 1 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.43%
Variación mensual
+9.05%
Variación en los últimos 6 meses
+24.87%
Cambio anual
+36.16%
Cierres anteriores
2.4 7
Open
2.4 1
Mínimo
2.4 1
Máximo
2.4 1
Volumen
59
Financials
- Market Capitalization 336.28 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.18
Relación precio/flujo de caja
53.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3215 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.45 USD | -4.04% | +1.34% | -13.27% | +17.60% | 339.08 M USD | ||
| 3218 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.92 USD | -1.99% | -3.43% | -5.43% | -13.45% | 338.53 M USD | ||
| 3260 |  IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | -4.22% | -5.67% | +22.00% | -11.52% | 322.84 M USD | ||
| 3265 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.29 USD | -2.76% | -0.94% | +4.13% | -4.34% | 319.85 M USD |